The U.S. Food and Drug Administration has urged online vendors to stop selling unapproved semaglutide and tirzepatide drugs due to public health concerns.
The U.S. Food and Drug Administration has urged online vendors to stop selling unapproved semaglutide and tirzepatide drugs due to public health concerns.